Virtual meeting
Via Zoom
Description
This training will discuss strategies to identify patients experiencing a stimulant overdose and will focus on particular strategies for the care of a patient experiencing an acute psychosis secondary to psychostimulant ingestion. The warning signs of psychostimulant overdose and strategies to mitigate the harm associated with the patient’s psychotic state will be discussed. De-escalation of patients experiencing psychosis secondary to psychostimulant intoxication in the clinic and community setting will be reviewed.
The harm reduction series is a 10-part education series for healthcare providers and SUD treatment programs to better understand Harm Reduction principles and harm reduction strategies as best practice in SUD treatment. The series will provide participants with an hour long didactic with a 30 minute Q+A. Each session is taught by an educator from the Grayken TTA team and an expert community member with boots on the ground experience in the specific topic area. Participants may attend all sessions or select specific courses. Continuing education credits are offered for each session.
Intended audience
Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and members of the community.
Speakers
Justin Alves, MSN, FNP-BC, ACRN, CARN, CNE (he/him)Rachel Xue, BA (she/her)
Rachel is the project management specialist for Boston Medical Center’s Stimulant Treatment and Recovery Team (START). She manages the design and implementation of operational and administrative infrastructure for the START program. She also manages a variety of projects, including contingency management implementation, monitoring, and compliance, documentation and data collection for START clinic and satellite locations to uphold grant activities and requirements. Additionally, she oversees and supports new stimulant clinics and engages others as needed to further disseminate evidence-based practices for substance use across the Commonwealth. Rachel earned her Bachelor of Arts in Biology from Boston University.
Objectives
Following this training, participants will have the knowledge necessary to:
- Review the epidemiology of stimulant use in the United States and the corresponding risk of psychostimulant overdose
- Identify the signs and symptoms of overamping
- Recognize the medical and psychological risks associated with overamping
- Employ the AGRO+ de-escalation strategy for patients experiencing overamping
- Devise strategies to reduce the risks of overamping as well as contingency plans for what to do if overamping should occur
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Credits
- CME (1.50)
- Nursing (1.50)
- Social work (1.50)
- LADC (1.50)
- CADC (1.50)
- Recovery coach (1.50)
- LMHC (1.50)
Visit the BMC Grayken Center for Addiction TTA website for accreditation information and to register: https://www.addictiontraining.org/training/register/event/?category=126&date=&type=&start=28&id=1357&pkIDed=1443
